HLA Class II Histocompatibility Antigen Gamma Chain (CD74) Peptide

Este producto es parte de CD74 - CD74 molecule
HLA Class II Histocompatibility Antigen Gamma Chain (CD74) Peptide

Pida mas información

935106861

info@markelab.com

Precio

175.5€ (100 µg)

Protein CD74

proveedor

Abbexa

reference

abx617249

Tested Applications

P-ELISA

reactivity

status

clonality

Descripción

HLA Class II Histocompatibility Antigen Gamma Chain (CD74) Peptide is a synthetic peptide.

Características del producto

category

Proteins and Peptides


host

Synthetic


immunogen target

HLA Class II Histocompatibility Antigen Gamma Chain (CD74)


host

Synthetic


conjugation

Unconjugated


form

Lyophilized Reconstitute in deionized water.


tested applications

P-ELISA


size 1

100 µg


observerd MW

Sequence Fragment: Internal region: C-HSLEQKPTDAPPK


recommended dilution

BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user.


buffer

Prior to lyophilization: Deionized water.


storage

Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.


or code

CD74


dry ice

No


availability

Shipped within 5-10 working days.


NCBI accession

NP_001020330.1, NP_004346.1


note

This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.


Quizá le pueda interesar

Human CD74(HLA class II histocompatibility antigen gamma chain) ELISA Kit

Human CD74(HLA class II histocompatibility antigen gamma chain) ELISA Kit

proveedor

FineTest

reference

EH1531

reactivity

human

status

RUO

Precio a consultar

Ver más

Mouse Cd74(HLA class II histocompatibility antigen gamma chain) ELISA Kit

Mouse Cd74(HLA class II histocompatibility antigen gamma chain) ELISA Kit

proveedor

FineTest

reference

EM6405

reactivity

mouse

status

RUO

Precio a consultar

Ver más

anti- CD74 antibody

anti- CD74 antibody

proveedor

FineTest

reference

FNab09829

Tested Applications

ELISA, WB

reactivity

human

status

RUO

clonality

monoclonal

Precio a consultar

Ver más